| P50 | author | Stanley J Szefler | Q65559413 |
| P2093 | author name string | Glenn Whelan | |
| | Melanie Gleason | |
| | Joseph D. Spahn | |
| P2860 | cites work | Asthma and wheezing in the first six years of life. The Group Health Medical Associates | Q72356528 |
| | A clinical index to define risk of asthma in young children with recurrent wheezing | Q73071756 |
| | Difficult-to-control asthma: clinical characteristics of steroid-insensitive asthma | Q74587031 |
| | National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics--2002 | Q78832828 |
| | Incentive to study drugs in children and other governmental initiatives: will patients with asthma benefit? | Q34030809 |
| | Childhood risk factors for atopy and the importance of early intervention | Q34214458 |
| | Challenges in assessing outcomes for pediatric asthma | Q34245756 |
| | Children with difficult asthma: a practical approach | Q34273468 |
| | Childhood asthma: new insights into management | Q34499666 |
| | The Melbourne Asthma Study: 1964-1999. | Q34528265 |
| | Budesonide inhalation suspension: a nebulized corticosteroid for persistent asthma | Q34592943 |
| | DNA therapy for asthma | Q34607962 |
| | Improving childhood asthma outcomes in the United States: a blueprint for policy action | Q34622037 |
| | Advances in childhood asthma: hygiene hypothesis, natural history, and management | Q35078579 |
| | Advances in allergic skin diseases | Q35078591 |
| | Relationship of adherence to pediatric asthma morbidity among inner-city children | Q39607065 |
| | Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: an analysis of asthma exacerbations | Q43601912 |
| | The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics | Q43723871 |
| | Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years | Q43726631 |
| | A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up | Q43821981 |
| | A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis | Q44198475 |
| | Omalizumab improves asthma-related quality of life in children with allergic asthma | Q44204121 |
| | Montelukast for respiratory syncytial virus bronchiolitis: significant effect or provocative findings? | Q44294567 |
| | Efficacy of omalizumab, an anti-immunoglobulin E antibody, in patients with allergic asthma at high risk of serious asthma-related morbidity and mortality. | Q51722262 |
| | Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group. | Q53535114 |
| | Long-term effects of budesonide or nedocromil in children with asthma. | Q53809666 |
| | Trends in childhood asthma: prevalence, health care utilization, and mortality | Q64127934 |
| | Therapeutic orphans | Q72015271 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | asthma | Q35869 |
| | immunology | Q101929 |
| | antiasthmatic | Q3618576 |
| | anti-allergic agents | Q50430264 |
| P304 | page(s) | 478-483 | |
| P577 | publication date | 2003-11-01 | |
| P1433 | published in | Current Allergy and Asthma Reports | Q2246111 |
| P1476 | title | The need for pediatric studies of allergy and asthma medications | |
| P478 | volume | 3 | |